Ocugen, Inc. (OCGN)
1.36
+0.01
(+0.74%)
USD |
NASDAQ |
Sep 04, 16:00
1.36
0.00 (0.00%)
After-Hours: 20:00
Ocugen Cash and Short Term Investments (Annual) : 18.57M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 18.57M |
| December 31, 2024 | 58.51M |
| December 31, 2023 | 39.46M |
| December 31, 2022 | 90.93M |
| December 31, 2021 | 94.96M |
| December 31, 2020 | 24.04M |
| December 31, 2019 | 7.444M |
| Date | Value |
|---|---|
| December 31, 2018 | 1.628M |
| December 31, 2017 | 7.981M |
| December 31, 2016 | 31.91M |
| December 31, 2015 | 30.92M |
| December 31, 2014 | 58.06M |
| December 31, 2013 | 8.734M |
| December 31, 2012 | 14.72M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 819.69M |
| Anika Therapeutics, Inc. | 57.48M |
| Gilead Sciences, Inc. | 9.613B |
| MannKind Corp. | 171.35M |
| Vertex Pharmaceuticals, Inc. | 6.611B |